| Examination of the synthetic control method for evaluating health policies with multiple treated units N Kreif, R Grieve, D Hangartner, AJ Turner, S Nikolova, M Sutton Health economics 25 (12), 1514-1528, 2016 | 370 | 2016 |
| Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population A Miners, A Phillips, N Kreif, A Rodger, A Speakman, M Fisher, ... The lancet HIV 1 (1), e32-e40, 2014 | 353 | 2014 |
| Estimating causal effects: considering three alternatives to difference-in-differences estimation S O’Neill, N Kreif, R Grieve, M Sutton, JS Sekhon Health Services and Outcomes Research Methodology 16, 1-21, 2016 | 253 | 2016 |
| Overview of parametric survival analysis for health-economic applications KJ Ishak, N Kreif, A Benedict, N Muszbek Pharmacoeconomics 31 (8), 663-675, 2013 | 123 | 2013 |
| Validation of the SF-36 in patients with endometriosis DE Stull, R Wasiak, N Kreif, M Raluy, A Colligs, C Seitz, C Gerlinger Quality of life research 23, 103-117, 2014 | 82 | 2014 |
| Statistical methods for cost‐effectiveness analyses that use observational data: A critical appraisal tool and review of current practice N Kreif, R Grieve, MZ Sadique Health economics 22 (4), 486-500, 2013 | 67 | 2013 |
| Machine Learning in Policy Evaluation: New Tools for Causal Inference N Kreif, K DiazOrdaz Oxford Research Encyclopedia of Economics and Finance, 2019 | 64 | 2019 |
| Evaluation of the effect of a continuous treatment: a machine learning approach with an application to treatment for traumatic brain injury N Kreif, R Grieve, I Díaz, D Harrison Health economics 24 (9), 1213-1228, 2015 | 64 | 2015 |
| Regression-adjusted matching and double-robust methods for estimating average treatment effects in health economic evaluation N Kreif, R Grieve, R Radice, JS Sekhon Health Services and Outcomes Research Methodology 13, 174-202, 2013 | 59 | 2013 |
| Evaluating treatment effectiveness in patient subgroups: a comparison of propensity score methods with an automated matching approach R Radice, R Ramsahai, R Grieve, N Kreif, Z Sadique, JS Sekhon The international journal of biostatistics 8 (1), 2012 | 57 | 2012 |
| What next after GDP-based cost-effectiveness thresholds? YL Chi, M Blecher, K Chalkidou, A Culyer, K Claxton, I Edoka, ... Gates open research 4, 2020 | 46 | 2020 |
| Machine learning methods in health economics and outcomes research—the PALISADE checklist: a good practices report of an ISPOR task force WV Padula, N Kreif, DJ Vanness, B Adamson, JD Rueda, F Felizzi, ... Value in health 25 (7), 1063-1080, 2022 | 42 | 2022 |
| A framework for conducting economic evaluations alongside natural experiments M Deidda, C Geue, N Kreif, R Dundas, E McIntosh Social science & medicine 220, 353-361, 2019 | 41 | 2019 |
| Methods for estimating subgroup effects in cost-effectiveness analyses that use observational data N Kreif, R Grieve, R Radice, Z Sadique, R Ramsahai, JS Sekhon Medical decision making 32 (6), 750-763, 2012 | 40 | 2012 |
| Evaluating treatment effectiveness under model misspecification: a comparison of targeted maximum likelihood estimation with bias-corrected matching N Kreif, S Gruber, R Radice, R Grieve, JS Sekhon Statistical methods in medical research 25 (5), 2315-2336, 2016 | 38 | 2016 |
| Estimating the comparative effectiveness of feeding interventions in the paediatric intensive care unit: a demonstration of longitudinal targeted maximum likelihood estimation N Kreif, L Tran, R Grieve, B deStavola, RC Tasker, M Petersen American Journal of Epidemiology, 2017 | 33 | 2017 |
| Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain E Calvo Aller, P Maroto, N Kreif, JL González Larriba, M López-Brea, ... Clinical and Translational Oncology 13, 869-877, 2011 | 31 | 2011 |
| Paying for efficiency: Incentivising same-day discharges in the English NHS J Gaughan, N Gutacker, K Grašič, N Kreif, L Siciliani, A Street Journal of health economics 68, 102226, 2019 | 25 | 2019 |
| ASTRA (Antiretrovirals, Sexual Transmission and Attitudes) Study. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross … A Miners, A Phillips, N Kreif, A Rodger, A Speakman, M Fisher, ... Lancet HIV 1 (1), e32-e40, 2014 | 25 | 2014 |
| Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer–a health-economic analysis based on the 100-month analysis of the … MP Lux, A Wöckel, A Benedict, S Buchholz, N Kreif, N Harbeck, ... Oncology Research and Treatment 33 (4), 155-166, 2010 | 25 | 2010 |
Richard GrieveProfessor of Health Economics Methodology在 lshtm.ac.uk 的电子邮件经过验证
